Evidence map›Paper›PMID 30965791›Full record

ArticlePolymers2017

Cluster Formation of Polyphilic Molecules Solvated in a DPPC Bilayer.

Xiang-Yang Guo, Christopher Peschel, Tobias Watermann, Guido Falk von Rudorff, Daniel Sebastiani

Abstract read
In one paragraph

Article in Polymers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiang-Yang GuoInstitute of Chemistry, MLU Halle-Wittenberg, von-Danckelmann-Platz 4, 06120 Halle, Germany. xiang.guo@chemie.uni-halle.de.
Christopher PeschelInstitute of Chemistry, MLU Halle-Wittenberg, von-Danckelmann-Platz 4, 06120 Halle, Germany. christopher.peschel@chemie.uni-halle.de.ORCID 0000-0002-4247-2191
Tobias WatermannInstitute of Chemistry, MLU Halle-Wittenberg, von-Danckelmann-Platz 4, 06120 Halle, Germany. tobias.watermann@chemie.uni-halle.de.
Guido Falk von RudorffInstitute of Chemistry, MLU Halle-Wittenberg, von-Danckelmann-Platz 4, 06120 Halle, Germany. guido@vonrudorff.de.
Daniel SebastianiInstitute of Chemistry, MLU Halle-Wittenberg, von-Danckelmann-Platz 4, 06120 Halle, Germany. daniel.sebastiani@chemie.uni-halle.de.ORCID 0000-0003-2240-3938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyse the initial stages of cluster formation of polyphilic additive molecules which are solvated in a dipalmitoylphosphatidylcholine (DPPC) lipid bilayer. Our polyphilic molecules comprise an aromatic (trans-bilayer) core domain with (out-of-bilayer) glycerol terminations, complemented with a fluorophilic and an alkyl side chain, both of which are confined within the aliphatic segment of the bilayer. Large-scale molecular dynamics simulations (1 μ s total duration) of a set of six of such polyphilic additives reveal the initial steps towards supramolecular aggregation induced by the specific philicity properties of the molecules. For our intermediate system size of six polyphiles, the transient but recurrent formation of a trimer is observed on a characteristic timescale of about 100 ns. The alkane/perfluoroalkane side chains show a very distinct conformational distribution inside the bilayer thanks to their different philicity, despite their identical anchoring in the trans-bilayer segment of the polyphile. The diffusive mobility of the polyphilic additives is about the same as that of the surrounding lipids, although it crosses both bilayer leaflets and tends to self-associate.

Indexed as

bolapolyphilediffusion coefficientDPPClipid bilayermolecular dynamics (MD)perfluorinated

Identifiers

PMID30965791
PMCPMC6418594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.